Levocetirizine Dihydrochloride

Product NDC
53217-375
11-digit product format
532170375
Labeler code
53217
Product ID
53217-375_345afcc5-23ac-4174-be4e-97a724db622d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Levocetirizine Dihydrochloride
Dosage form
TABLET
Route
ORAL
Labeler
Aidarex Pharmaceuticals LLC
Application
ANDA203027
Marketing category
ANDA
Marketing start
2018-04-17
Marketing end
0000-00-00
Substance
LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength
5 mg/1
Pharmacologic classes
Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
36cf9111-9cc4-8f59-a74c-0c1cfbd4a760Product name720190702

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53217-375-30Levocetirizine Dihydrochloride30 in 1 BOTTLETABLET301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53217-375LEVOCETIRIZINE DIHYDROCHLORIDE TABLET [AIDAREX PHARMACEUTICALS LLC]1Legacy NDC, 1 package rows20180823_1efcf912-1187-4d69-895c-30d363e5eb7a.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
855172levocetirizine dihydrochloride 5 MG Oral TabletPSN1efcf912-1187-4d69-895c-30d363e5eb7a1
855172levocetirizine dihydrochloride 5 MG Oral TabletSCD1efcf912-1187-4d69-895c-30d363e5eb7a1
855172levocetirizine dihydrochloride 5 MG 24 HR Oral TabletSY1efcf912-1187-4d69-895c-30d363e5eb7a1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
53217-375-305321703753030 in 1 BOTTLEHistorical